Raymond James Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Raymond James Financial’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.9M	Buy	221,361 +18,484	+9%	+$3.98M	0.01%	890
2026 Q1	$40.7M	Buy	202,877 +57,218	+39%	+$11.8M	0.01%	987
2025 Q4	$30.1M	Buy	145,659 +8,115	+6%	+$1.62M	0.01%	1165
2025 Q3	$24.7M	Sell	137,544 -6,747	-5%	-$1.15M	0.01%	1269
2025 Q2	$23.3M	Sell	144,291 -12,212	-8%	-$1.95M	0.01%	1246
2025 Q1	$26.6M	Sell	156,503 -10,543	-6%	-$1.83M	0.01%	1096
2024 Q4	$27.8M	Buy	+167,046	New	+$28.5M	0.01%	1089

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Raymond James Financial's FBT Position: Q2 2026 in Review

Raymond James Financial increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 9.1% in Q2 2026, buying an estimated $3.98M and bringing the position to 221,361 shares worth $54.9M. The position accounts for 0.01% of the portfolio, ranked #890.

Raymond James Financial first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Raymond James Financial held 221,361 shares of First Trust NYSE Arca Biotechnology Index Fund worth $54.9M as of Q2 2026.
Raymond James Financial bought 18,484 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.98M.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #890 holding.
Raymond James Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.